<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Arum O</submitter><funding>NIA NIH HHS</funding><pagination>117-27</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3889906</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>36(1)</volume><pubmed_abstract>Neuromusculoskeletal (physical) frailty is an aging-attributable biomedical issue of extremely high import, from both public health and individual perspectives. Yet, it is rarely studied in nonhuman research subjects and very rarely studied in animals with extended longevity. In an effort to address this relatively neglected area, we have conducted a longitudinal investigation of the neuromusculoskeletal healthspan in mice with two senescence-slowing interventions: growth hormone (GH) resistance, produced by GH receptor "knockout" (GHR-KO), and caloric restriction (CR). We report marked improvements in the retention of strength, balance, and motor coordination by the longevity-conferring GHR/BP gene disruption, CR regimen, or a combination of the two. Specifically, GHR-KO mice exhibit supe</pubmed_abstract><journal>Age (Dordrecht, Netherlands)</journal><pubmed_title>The slow-aging growth hormone receptor/binding protein gene-disrupted (GHR-KO) mouse is protected from aging-resultant neuromusculoskeletal frailty.</pubmed_title><pmcid>PMC3889906</pmcid><funding_grant_id>AG19899</funding_grant_id><funding_grant_id>R01 AG019899</funding_grant_id><funding_grant_id>3R01AG019899-07S1</funding_grant_id><funding_grant_id>U19 AG023122</funding_grant_id><pubmed_authors>Arum O</pubmed_authors><pubmed_authors>Kopchick JJ</pubmed_authors><pubmed_authors>Rickman DJ</pubmed_authors><pubmed_authors>Bartke A</pubmed_authors></additional><is_claimable>false</is_claimable><name>The slow-aging growth hormone receptor/binding protein gene-disrupted (GHR-KO) mouse is protected from aging-resultant neuromusculoskeletal frailty.</name><description>Neuromusculoskeletal (physical) frailty is an aging-attributable biomedical issue of extremely high import, from both public health and individual perspectives. Yet, it is rarely studied in nonhuman research subjects and very rarely studied in animals with extended longevity. In an effort to address this relatively neglected area, we have conducted a longitudinal investigation of the neuromusculoskeletal healthspan in mice with two senescence-slowing interventions: growth hormone (GH) resistance, produced by GH receptor "knockout" (GHR-KO), and caloric restriction (CR). We report marked improvements in the retention of strength, balance, and motor coordination by the longevity-conferring GHR/BP gene disruption, CR regimen, or a combination of the two. Specifically, GHR-KO mice exhibit supe</description><dates><release>2014-01-01T00:00:00Z</release><publication>2014 Feb</publication><modification>2025-04-04T21:13:59.495Z</modification><creation>2019-03-27T01:19:55Z</creation></dates><accession>S-EPMC3889906</accession><cross_references><pubmed>23824747</pubmed><doi>10.1007/s11357-013-9551-x</doi></cross_references></HashMap>